NCT04900948 - Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

December 10, 2017

Primary Completion Date

April 25, 2020

Study Completion Date

April 25, 2020

Conditions

Atopic Dermatitis

Interventions

DRUG

Pimecrolimus cream 1%

Patients received pimecrolimus cream 1% 2 times a day for 3 months. Then use in a double application mode (morning / evening) 3 times a week for up to 1 year of age. Also, patients used emollients 1-2 times a day.

DRUG

cream 0.1% methylprednisolone aceponate

Patients received 0.1% methylprednisolone aceponate cream 2 times a week for 3 months, and then used for exacerbation of atopic dermatitis. Also, patients used emollients 1-2 times a day.

Trial Locations (1)

119296

National Medical Research Center for Children's Health, Moscow

All Listed Sponsors

lead

National Medical Research Center for Children's Health, Russian Federation

OTHER_GOV